Article

Orphan Drug Cost Controversy Highlights AJPB Week in Review

Author(s):

Davy James, Managing Editor

Top articles of the week from The American Journal of Pharmacy Benefits.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
1 expert in this video
1 expert in this video
Austin Texas | Image credit: Kevin Ruck - stock.adobe.com
Pharmacy Times OPC
Related Content
PCAB Accreditation as a Safety Net: GLP-1 Demand and the Spotlight on Compounding Standards
June 27th 2025

PCAB Accreditation as a Safety Net: GLP-1 Demand and the Spotlight on Compounding Standards

Karen Spano, RPh, HDDP
Pharmacy Times, Pharmacy Focus Oncology Edition
June 27th 2025

Allen's Story: The Promising Potential of Intratumoral Immunotherapy

Alexandra Gerlach, Associate Editor
Illustration of immunotherapy attacking multiple myeloma cells | Image Credit: © Noel - stock.adobe.com
June 27th 2025

Is Belantamab Mafodotin Making a Comeback?

Alexandra Gerlach, Associate Editor
Concierge Pharmacy's Role in Cardio-Kidney-Metabolic Health Care
June 17th 2025

Concierge Pharmacy's Role in Cardio-Kidney-Metabolic Health Care

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP Aislinn Antrim, Managing Editor
Medical Misinformation Affects Public Understanding of Long COVID
June 27th 2025

Medical Misinformation Affects Public Understanding of Long COVID

Camille Cabas, PharmD
Mantle cell lymphoma -- Image credit: David A Litman | stock.adobe.com
June 27th 2025

New Frontline BTK Inhibitor Strategy Gains FDA Approval in Untreated Mantle Cell Lymphoma

Ami Ali, PharmD, BCOP Mary Dzhuryan, PharmD Candidate Mehrnaz Razavi Vakhshoori, PharmD Candidate